Hayaishi-Okano Rieko, Yamasaki Yoshimitsu, Kajimoto Yoshitaka, Sakamoto Ken'ya, Ohtoshi Kentaro, Katakami Naoto, Kawamori Dan, Miyatsuka Takeshi, Hatazaki Masahiro, Hazama Yoji, Hori Masatsugu
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Yamadaoka Suita City, Japan.
Diabetes Care. 2003 Feb;26(2):458-63. doi: 10.2337/diacare.26.2.458.
To evaluate the association between the C242T polymorphism of the p22 phox gene, an essential component of NAD(P)H oxidase in the vasculature, with intima-media thickness (IMT) of the carotid artery and risk factors for atherosclerosis in type 2 diabetic subjects.
C242T polymorphism of the p22 phox gene was detected by polymerase chain reaction-restriction fragment-length polymorphism in 200 Japanese type 2 diabetic subjects and 215 nondiabetic subjects. We examined the association with this mutation and carotid atherosclerosis as well as the patients' clinical characteristics and the level of 8-hydroxy-2'deoxyguanosine (8-OHdG) as an index of oxidative DNA damage.
The diabetic subjects with the TC+TT genotypes displayed a significantly lower average IMT (1.13 +/- 0.31 vs. 1.31 +/- 0.34 mm; P = 0.0099) and a not significantly lower serum 8-OHdG level than those with the CC genotype, despite no difference in the risk factors. Stepwise multiple regression analysis showed that the risk factors for increased IMT in the diabetic subjects were systolic blood pressure (P = 0.0042) and p22 phox CC genotype (P = 0.0151). In nondiabetic subjects, the average IMT of the TC+TT group was not different from that of the CC group (0.85 +/- 0.14 vs. 0.94 +/- 0.30 mm, P = 0.417). Fasting plasma insulin concentration (41.4 +/- 15.6 vs. 64.2 +/- 59.4 pmol/l, P = 0.0098) and insulin resistance index of homeostasis model assessment (HOMA-R) (1.58 +/- 0.66 vs. 2.60 +/- 2.56, P = 0.0066) were significantly lower in the TC+TT group than in the CC group.
These results show that the C242T mutation in the p22 phox gene is associated with progression of asymptomatic atherosclerosis in the subjects with type 2 diabetes and is also associated with insulin resistance in nondiabetic subjects.
评估血管中烟酰胺腺嘌呤二核苷酸磷酸(NAD(P)H)氧化酶的重要组成部分p22吞噬氧化酶基因的C242T多态性与2型糖尿病患者颈动脉内膜中层厚度(IMT)及动脉粥样硬化危险因素之间的关联。
采用聚合酶链反应-限制性片段长度多态性方法,对200例日本2型糖尿病患者和215例非糖尿病患者检测p22吞噬氧化酶基因的C242T多态性。我们研究了该突变与颈动脉粥样硬化的关联,以及患者的临床特征和作为氧化DNA损伤指标的8-羟基-2'-脱氧鸟苷(8-OHdG)水平。
尽管危险因素无差异,但TC+TT基因型的糖尿病患者平均IMT显著低于CC基因型患者(1.13±0.31 vs. 1.31±0.34 mm;P = 0.0099),血清8-OHdG水平虽有降低但差异不显著。逐步多元回归分析显示,糖尿病患者IMT增加的危险因素为收缩压(P = 0.0042)和p22吞噬氧化酶CC基因型(P = 0.0151)。在非糖尿病患者中,TC+TT组的平均IMT与CC组无差异(0.85±0.14 vs. 0.94±0.30 mm,P = 0.417)。TC+TT组的空腹血浆胰岛素浓度(41.4±15.6 vs. 64.2±59.4 pmol/l,P = 0.0098)和稳态模型评估胰岛素抵抗指数(HOMA-R)(1.58±0.66 vs. 2.60±2.56,P = 0.0066)显著低于CC组。
这些结果表明,p22吞噬氧化酶基因的C242T突变与无症状动脉粥样硬化在2型糖尿病患者中的进展相关,并且在非糖尿病患者中也与胰岛素抵抗相关。